Avior Wealth Management’s Legend Biotech LEGN Stock Holding History

Avior Wealth Management’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$235K	Buy	+8,133	New	+$219K	0.01%	715
2025 Q4	–	Sell	-8,140	Closed	-$265K	–	764
2025 Q3	$265K	Sell	8,140 -3,662	-31%	-$135K	0.01%	633
2025 Q2	$419K	Sell	11,802 -3,100	-21%	-$100K	0.01%	481
2025 Q1	$506K	Buy	14,902 +4,686	+46%	+$168K	0.02%	402
2024 Q4	$332K	Sell	10,216 -881	-8%	-$36.5K	0.01%	566
2024 Q3	$541K	Buy	11,097 +323	+3%	+$17.2K	0.02%	429
2024 Q2	$477K	Buy	+10,774	New	+$497K	0.02%	445
2024 Q1	–	Sell	-7,396	Closed	-$446K	–	3859
2023 Q4	$445K	Buy	7,396 +182	+3%	+$11.5K	0.03%	369
2023 Q3	$485K	Buy	7,214 +2,421	+51%	+$168K	0.03%	338
2023 Q2	$331K	Buy	+4,793	New	+$313K	0.02%	431

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Avior Wealth Management's LEGN Position: Q2 2026 in Review

Avior Wealth Management opened a new position in Legend Biotech (LEGN) in Q2 2026: 8,133 shares worth $235K. The stake represents 0.01% of the portfolio and ranks #715 among its holdings. This is a return to the name: Avior Wealth Management previously reported a position in LEGN as recently as Q3 2025.

Avior Wealth Management first reported a position in LEGN in Q2 2023 and has held it in 10 quarters since. The position peaked at $541K in Q3 2024. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

Avior Wealth Management held 8,133 shares of Legend Biotech worth $235K as of Q2 2026.
Legend Biotech was a new Avior Wealth Management position in Q2 2026.
Legend Biotech made up 0.01% of Avior Wealth Management's portfolio in Q2 2026, its #715 holding.
Avior Wealth Management first reported a position in Legend Biotech in Q2 2023 and has held it in 10 quarters since.
Avior Wealth Management's Legend Biotech position peaked at $541K in Q3 2024.
218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Avior Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.